Font Size: a A A
Keyword [receptor tyrosine kinase]
Result: 121 - 140 | Page: 7 of 10
121. The Differences Of Efficacy Of Chemotherapy And Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor In Advanced Lung Adenocarcinoma Patients Harboring 19del And L858R Mutation
122. Comparison Of The Clinical Outcome Of Gefitinib For Advanced Lung Adenocarcinoma With Positive Epidermal Growth Factor Receptor Mutated In Exon 21 Or 19 Del Between Patients Treated With First And Second Line Therapy
123. Non-small Cell Lung Cancer NCI-H460 Cell Driven Receptor Tyrosine Kinase High-Expression Molecular Regulation Mechansim Research
124. Role Of EMT In Radiosensitivity Of NSCLC With Acquired Resistance Of EGFR-TKI
125. Efficacy And Safety Of Stereotactic Body Radiation Therapy In The Management Of Oligopersistent Disease In Patients With Egfr Mutant Non-small Cell Lung Cancer During EGFR-TKIs Treatment
126. The Clinical Study And The Mechanism On The Reversion Of Acquired Resistance With The First Generation EGRF-TKIs For Advanced NSCLC Patients
127. Discovery Of Novel Type ? Kinase Inhibitors For Class ? Tyrosine Kinases
128. Clinical Studies And Prognostic Analysis Of Leptomeningeal Metastases From Lung Cancer And Adenosquamous Lung Carcinoma
129. Establishment Of Third Generation EGFR-TKI Osimertinib Acquired Resistant NSCLC Cell Line And Preliminary Study On Resistance Mechanism
130. Clinical And Experimental Study On The Relationship Between Hyperglycemia And Gastrointestinal Stromal Tumor
131. The Role Of Local Ablation Thepray For Advanced EGFR-mutant NSCLC Patients With Oligometastatic Disease Or Oligoprogressive Disease
132. The Effect And Molecular Mechanism Of Multikinase Inhibitor PKC412 In Colorectal Cancer Cells
133. Proteomics In Non-Small Cell Lung Cancer Patients For Prediction Of Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Chemotherapy
134. Study Of Anti-ovarian Cancer Effects And Mechanisms Induced By Ovarian Cancer Stem Cell Vaccines
135. Function And Mechanism Of Receptor Tyrosine Kinase TIE In Vascular Development And Maintenance
136. The Role Of Rerum VEGF In Determining EGFR-TKI Acquired Resistance In Lung Adenocarcinoma
137. Serum Albumin And CEA Are Associated With Prognosis Of EGFR-TKI Treatment In Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
138. The Effect Of Non-receptor Tyrosine Kinase BMX On LPS-stimulated Macrophage In Secretion Of Pro-inflammatory Cytokine TNF-? And Phagocytosis Of E.coli
139. Effects Of Non-receptor Tyrosine Kinase Abelson On Autophagy Inhibited By 1-methyl-4-phenylpyridinium Ion In Mouse SN4741 Cells
140. Studies On The Interaction Between Mutant Soluble Ectodomain Of Human Fibroblast Growth Factor Receptor 2?c(ms FGFR2c) And EGFR
  <<First  <Prev  Next>  Last>>  Jump to